These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3022508)

  • 1. Symposium: Converting enzyme inhibition. New trends in the treatment of hypertension and congestive heart failure. Brussels, Belgium, June 21, 1985.
    Acta Cardiol; 1986; 41(5):329-96. PubMed ID: 3022508
    [No Abstract]   [Full Text] [Related]  

  • 2. A new angiotensin-converting enzyme inhibitor: treatment of hypertension and congestive heart failure. Proceedings of an international symposium on enalapril, sponsored by Merck Sharp & Dohme International, São Paulo, Brazil, November 10, 1984.
    Drugs; 1985; 30 Suppl 1():1-96. PubMed ID: 2994983
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril.
    Brunner HR; Nussberger J; Waeber B
    Acta Cardiol; 1986; 41(5):341-50. PubMed ID: 3022510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lisinopril: a new ACE inhibitor for the treatment of hypertension and congestive heart failure.
    Chodoff L
    Mt Sinai J Med; 1990 May; 57(3):169-71. PubMed ID: 2164644
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril: a new angiotensin-converting enzyme inhibitor.
    McRaith J; Fitz A
    Iowa Med; 1986 Oct; 76(10):482, 484, 486-8. PubMed ID: 3023256
    [No Abstract]   [Full Text] [Related]  

  • 7. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new angiotensin-converting enzyme inhibitor is imminent].
    Michel D
    Fortschr Med; 1988 Jul; 106(22):463-6. PubMed ID: 2851512
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of enalapril. Summing up the evidence.
    Dollery CT
    J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril and QTC dispersion in congestive heart failure.
    Brockmeier LB
    Am J Cardiol; 1997 Dec; 80(12):1643. PubMed ID: 9416960
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical pharmacology of enalapril.
    Gomez HJ; Cirillo VJ; Jones KH
    J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting enzyme inhibition for understanding and management of hypertensive disorders and congestive heart failure. Symposium, Anaheim, California, November 13, 1983.
    Am J Med; 1984 Aug; 77(2A):1-86. PubMed ID: 6089553
    [No Abstract]   [Full Text] [Related]  

  • 14. Lisinopril for hypertension.
    Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
    Lantz P; Enghoff E; Hedlund A; Hägg A
    Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties.
    Jerie P; Kremer HJ
    Cor Vasa; 1992; 34(1):82-7. PubMed ID: 1288944
    [No Abstract]   [Full Text] [Related]  

  • 17. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ; Laragh JH; Atlas SA; Case DB
    J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.